| Literature DB >> 35744717 |
Gopal R Gopinath1, Hyein Jang1, Junia Jean-Gilles Beaubrun1,2, Jayanthi Gangiredla1, Mark K Mammel1, Andrea Müller3, Sandeep Tamber4, Isha R Patel1, Laura Ewing1, Leah M Weinstein1, Caroline Z Wang1, Samantha Finkelstein1, Flavia Negrete1, Tim Muruvanda5, Marc Allard5, Donald C Sockett6, Franco Pagotto4, Ben D Tall1, Roger Stephan3.
Abstract
Salmonella enterica subsp. enterica serovar Bovismorbificans has caused multiple outbreaks involving the consumption of produce, hummus, and processed meat products worldwide. To elucidate the intra-serovar genomic structure of S. Bovismorbificans, a core-genome analysis with 2690 loci (based on 150 complete genomes representing Salmonella enterica serovars developed as part of this study) and a k-mer-binning based strategy were carried out on 95 whole genome sequencing (WGS) assemblies from Swiss, Canadian, and USA collections of S. Bovismorbificans strains from foodborne infections. Data mining of a digital DNA tiling array of legacy SARA and SARB strains was conducted to identify near-neighbors of S. Bovismorbificans. The core genome analysis and the k-mer-binning methods identified two polyphyletic clusters, each with emerging evolutionary properties. Four STs (2640, 142, 1499, and 377), which constituted the majority of the publicly available WGS datasets from >260 strains analyzed by k-mer-binning based strategy, contained a conserved core genome backbone with a different evolutionary lineage as compared to strains comprising the other cluster (ST150). In addition, the assortment of genotypic features contributing to pathogenesis and persistence, such as antimicrobial resistance, prophage, plasmid, and virulence factor genes, were assessed to understand the emerging characteristics of this serovar that are relevant clinically and for food safety concerns. The phylogenomic profiling of polyphyletic S. Bovismorbificans in this study corresponds to intra-serovar variations observed in S. Napoli and S. Newport serovars using similar high-resolution genomic profiling approaches and contributes to the understanding of the evolution and sequence divergence of foodborne Salmonellae. These intra-serovar differences may have to be thoroughly understood for the accurate classification of foodborne Salmonella strains needed for the uniform development of future food safety mitigation strategies.Entities:
Keywords: Salmonella Bovismorbificans; phages; phylogenomics; plasmids; virulence factors
Year: 2022 PMID: 35744717 PMCID: PMC9228720 DOI: 10.3390/microorganisms10061199
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
Strain information (Strain name, Source, Country, Year of isolation, and Reference), genomic characterization (Genome size, No. of CDSs, and Sequence Type), NCBI Biosample, and GenBank accession numbers of 95 S. Bovismorbificans isolates used in this study.
| Strain | Source | Country | Year | Genome | No. of | ST a | NCBI | NCBI | Reference |
|---|---|---|---|---|---|---|---|---|---|
| M18_12182 | Environment | USA | 2018 | 4679 | 4399 | 150 | SAMN12657258 | WSCV00000000 | This study |
| Bovis_38 | Beef | Canada | 1989 | 4579 | 4321 | 142 | SAMN12657217 | WSCW00000000 | This study |
| Bovis_120 | Seafood, squid | Canada | missing | 4706 | 4474 | 1499 | SAMN12657218 | WSCX00000000 | This study |
| Bovis_187 | Seafood, shrimp | Canada | 1989 | 4739 | 4498 | 1499 | SAMN12657204 | WSCY00000000 | This study |
| Bovis_277 | Clinical | Canada | 1984 | 4832 | 4638 | 1499 | SAMN12657210 | WSCZ00000000 | This study |
| Bovis_278 | Clinical | Canada | 1984 | 4738 | 4498 | 142 | SAMN12657232 | WSDA00000000 | This study |
| N14_0147 | Clinical | Switzerland | 2014 | 4690 | 4471 | 142 | SAMN12657231 | WSDB00000000 | This study |
| N14_0646 | Clinical | Switzerland | 2014 | 4702 | 4449 | 1499 | SAMN12657228 | WSDC00000000 | This study |
| N14_1189 | Clinical | Switzerland | 2014 | 4790 | 4575 | 142 | SAMN12657257 | WSDD00000000 | This study |
| N14_1190 | Clinical | Switzerland | 2014 | 4784 | 4566 | 142 | SAMN12657229 | WSDE00000000 | This study |
| N14_1194 | Clinical | Switzerland | 2014 | 4789 | 4580 | 142 | SAMN12657219 | WSDF00000000 | This study |
| N14_1212 | Clinical | Switzerland | 2014 | 4790 | 4577 | 142 | SAMN12657254 | WSDG00000000 | This study |
| N14_1217 | Clinical | Switzerland | 2014 | 4854 | 4688 | 142 | SAMN12657212 | WSDH00000000 | This study |
| N14_1222 | Clinical | Switzerland | 2014 | 4791 | 4577 | 142 | SAMN12657214 | WSDI00000000 | This study |
| N14_1232 | Clinical | Switzerland | 2014 | 4778 | 4560 | 142 | SAMN12657205 | WSDJ00000000 | This study |
| N14_1233 | Clinical | Switzerland | 2014 | 4790 | 4568 | 142 | SAMN12657209 | WSDK00000000 | This study |
| N14_1237 | Clinical | Switzerland | 2014 | 4781 | 4565 | 142 | SAMN12657230 | WSDL00000000 | This study |
| N14_1238 | Clinical | Switzerland | 2014 | 4781 | 4563 | 142 | SAMN12657235 | WSDM00000000 | This study |
| N14_1239 | Clinical | Switzerland | 2014 | 4778 | 4562 | 142 | SAMN12657165 | WSDN00000000 | This study |
| N14_1252 | Clinical | Switzerland | 2014 | 4781 | 4562 | 142 | SAMN12657181 | WSDO00000000 | This study |
| N14_1255 | Clinical | Switzerland | 2014 | 4786 | 4576 | 142 | SAMN12657154 | WSDP00000000 | This study |
| N14_1266 | Clinical | Switzerland | 2014 | 4779 | 4561 | 142 | SAMN12657194 | WSDQ00000000 | This study |
| N14_1267 | Clinical | Switzerland | 2014 | 4775 | 4602 | 142 | SAMN12657197 | WSDR00000000 | This study |
| N14_1268 | Clinical | Switzerland | 2014 | 4783 | 4567 | 142 | SAMN12657192 | WSDS00000000 | This study |
| N14_1285 | Clinical | Switzerland | 2014 | 4780 | 4561 | 142 | SAMN12657190 | WSDT00000000 | This study |
| N14_1527 | Clinical | Switzerland | 2014 | 4813 | 4590 | 1499 | SAMN12657150 | WSDU00000000 | This study |
| N14_1673 | Clinical | Switzerland | 2014 | 4819 | 4609 | 142 | SAMN12657188 | WSDV00000000 | This study |
| N14_1674 | Clinical, blood | Switzerland | 2014 | 4783 | 4571 | 142 | SAMN12657156 | WSDW00000000 | This study |
| N14_1962 | Clinical | Switzerland | 2014 | 4715 | 4468 | 1499 | SAMN12657164 | WSDX00000000 | This study |
| N14_2376 | Food, onion | Switzerland | 2014 | 4723 | 4486 | 377 | SAMN12657147 | WSDY00000000 | This study |
| N15_0039 | Food, grain | Switzerland | 2015 | 4726 | 4493 | 377 | SAMN12657185 | WSDZ00000000 | This study |
| N15_0111 | Clinical | Switzerland | 2015 | 5024 | 4860 | 1499 | SAMN12657157 | WSEA00000000 | This study |
| N15_0387 | Clinical | Switzerland | 2015 | 4643 | 4404 | 142 | SAMN12657198 | WSEB00000000 | This study |
| N15_0584 | Clinical | Switzerland | 2015 | 4670 | 4468 | 142 | SAMN12657182 | WSEC00000000 | This study |
| N15_1010 | Food | Switzerland | 2015 | 4725 | 4483 | 377 | SAMN12657196 | WSED00000000 | This study |
| N15_1120 | Food | Switzerland | 2015 | 4724 | 4486 | 377 | SAMN12657193 | WSEE00000000 | This study |
| N15_1199 | Food | Switzerland | 2015 | 4720 | 4485 | 377 | SAMN12657191 | WSEF00000000 | This study |
| N15_1496 | Clinical | Switzerland | 2015 | 4738 | 4530 | 142 | SAMN12657189 | WSEG00000000 | This study |
| N15_2048 | Clinical | Switzerland | 2015 | 4847 | 4671 | 1499 | SAMN12657202 | WSEH00000000 | This study |
| N15_2285 | Clinical | Switzerland | 2015 | 4806 | 4598 | 377 | SAMN12657199 | WSEI00000000 | This study |
| N15_2358 | Clinical | Switzerland | 2015 | 4893 | 4724 | 377 | SAMN12657233 | WSEJ00000000 | This study |
| N16_0208 | Clinical | Switzerland | 2016 | 4798 | 4571 | 1499 | SAMN12657155 | WSBH00000000 | This study |
| N16_0447 | Clinical, urine | Switzerland | 2016 | 4636 | 4399 | 142 | SAMN12657160 | WSBI00000000 | This study |
| N16_0656 | Clinical | Switzerland | 2016 | 4838 | 4628 | 2640 | SAMN12657256 | WSBJ00000000 | This study |
| N16_1158 | Clinical | Switzerland | 2016 | 4781 | 4566 | 142 | SAMN12657253 | WSBK00000000 | This study |
| N16_1250 | Clinical | Switzerland | 2016 | 4788 | 4571 | 142 | SAMN12657211 | WSBL00000000 | This study |
| N16_1558 | Clinical | Switzerland | 2016 | 4571 | 4290 | 150 | SAMN12657220 | WSBM00000000 | This study |
| N16_1675 | Clinical | Switzerland | 2016 | 4782 | 4573 | 142 | SAMN12657207 | WSBN00000000 | This study |
| N16_1715 | Clinical | Switzerland | 2016 | 4784 | 4570 | 142 | SAMN12657200 | WSBO00000000 | This study |
| N16_1722 | Clinical | Switzerland | 2016 | 4785 | 4569 | 142 | SAMN12657206 | WSBP00000000 | This study |
| N16_1740 | Clinical | Switzerland | 2016 | 4778 | 4556 | 142 | SAMN12657234 | WSBQ00000000 | This study |
| N16_1757 | Clinical | Switzerland | 2016 | 4784 | 4568 | 142 | SAMN12657203 | WSBR00000000 | This study |
| N16_1786 | Clinical | Switzerland | 2016 | 4781 | 4567 | 142 | SAMN12657259 | WSBS00000000 | This study |
| N16_1788 | Clinical | Switzerland | 2016 | 4784 | 4584 | 142 | SAMN12657260 | WSBT00000000 | This study |
| N16_1794 | Clinical | Switzerland | 2016 | 4794 | 4573 | 142 | SAMN12657221 | WSBU00000000 | This study |
| N16_1829 | Clinical | Switzerland | 2016 | 4785 | 4571 | 142 | SAMN12657255 | WSBV00000000 | This study |
| N16_2042 | Clinical | Switzerland | 2016 | 4778 | 4561 | 142 | SAMN12657208 | WSBW00000000 | This study |
| N16_2132 | Clinical | Switzerland | 2016 | 4787 | 4563 | 142 | SAMN12657216 | WSBX00000000 | This study |
| N16_2207 | Animal, cat | Switzerland | 2016 | 4778 | 4573 | 142 | SAMN12657146 | WSBY00000000 | This study |
| N16_2424 | Clinical | Switzerland | 2016 | 4775 | 4556 | 142 | SAMN12657163 | WSBZ00000000 | This study |
| N16_2574 | Clinical | Switzerland | 2016 | 4947 | 4754 | 142 | SAMN12657148 | WSCA00000000 | This study |
| N16_2598 | Clinical | Switzerland | 2016 | 4706 | 4481 | 142 | SAMN12657161 | WSCB00000000 | This study |
| N16_2682 | Clinical | Switzerland | 2016 | 4777 | 4574 | 142 | SAMN12657159 | WSCC00000000 | This study |
| N16_2712 | Clinical | Switzerland | 2016 | 4703 | 4489 | 142 | SAMN12657184 | WSCD00000000 | This study |
| N16_2718 | Clinical | Switzerland | 2016 | 4723 | 4482 | 377 | SAMN12657144 | WSCE00000000 | This study |
| N16_2802 | Clinical | Switzerland | 2016 | 4724 | 4508 | 142 | SAMN12657195 | WSCF00000000 | This study |
| N16_2849 | Clinical | Switzerland | 2016 | 4725 | 4489 | 377 | SAMN12657142 | WSCG00000000 | This study |
| N16_2955 | Clinical | Switzerland | 2016 | 4811 | 4599 | 1499 | SAMN12657187 | WSCH00000000 | This study |
| N17_0002 | Clinical | Switzerland | 2017 | 4706 | 4492 | 142 | SAMN12657149 | WSCI00000000 | This study |
| N17_0502 | Clinical | Switzerland | 2017 | 4873 | 4696 | 1499 | SAMN12657152 | WSCJ00000000 | This study |
| N17_0607 | Clinical | Switzerland | 2017 | 4640 | 4401 | 142 | SAMN12657145 | WSCK00000000 | This study |
| N17_0620 | Food | Switzerland | 2017 | 4731 | 4493 | 377 | SAMN12657151 | WSCL00000000 | This study |
| N17_0857 | Feed | Switzerland | 2017 | 4724 | 4507 | 377 | SAMN12657158 | WSCM00000000 | This study |
| N17_1212 | Clinical | Switzerland | 2017 | 4773 | 4576 | 2640 | SAMN12657162 | WSCN00000000 | This study |
| N17_1364 | Clinical | Switzerland | 2017 | 4869 | 4680 | 2640 | SAMN12657186 | WSCO00000000 | This study |
| N17_1393 | Clinical | Switzerland | 2017 | 4779 | 4564 | 2640 | SAMN12657153 | WSCP00000000 | This study |
| N17_2111 | Clinical | Switzerland | 2017 | 4775 | 4561 | 2640 | SAMN12657143 | WSCQ00000000 | This study |
| N18_0002 | Clinical | Switzerland | 2018 | 4805 | 4605 | 142 | SAMN12657183 | WSCR00000000 | This study |
| N18_0969 | Clinical | Switzerland | 2018 | 4640 | 4402 | 142 | SAMN12657213 | WSCS00000000 | This study |
| N18_1092 | Clinical | Switzerland | 2018 | 4728 | 4492 | 377 | SAMN12657215 | WSCT00000000 | This study |
| N18_1144 | Clinical | Switzerland | 2018 | 4722 | 4544 | 377 | SAMN12657201 | WSCU00000000 | This study |
| Sal609 b | Clinical | USA | 2011 | 4896 | 4925 | 377 | SAMN02422699 | AZKW00000000 | [ |
| Sal610 | Clinical | USA | 2011 | 4857 | 4870 | 377 | SAMN02422700 | AZKX00000000 | [ |
| Sal615 | Clinical | USA | 2011 | 4845 | 4891 | 377 | SAMN02422701 | AZKY00000000 | [ |
| Sal616 | Food | USA | 2011 | 4865 | 4893 | 377 | SAMN02422702 | AZKZ00000000 | [ |
| Sal617 | Food | USA | 2011 | 4872 | 4887 | 377 | SAMN02422703 | AZLA00000000 | [ |
| Sal644 | Clinical | USA | 2001 | 4769 | 4769 | 1499 | SAMN02422688 | AZLC00000000 | [ |
| Sal676 | Clinical | USA | 2012 | 4569 | 4476 | 150 | SAMN02422698 | AZKV00000000 | [ |
| Sal677 | Clinical | USA | 2012 | 4663 | 4614 | 150 | SAMN02422693 | AZKR00000000 | [ |
| Sal678 | Clinical | USA | 2012 | 4579 | 4629 | 150 | SAMN02422694 | AZKS00000000 | [ |
| Sal679 | Clinical | USA | 2012 | 4567 | 4471 | 150 | SAMN02422695 | AZKT00000000 | [ |
| Sal680 | Clinical | USA | 2012 | 4596 | 4506 | 150 | SAMN02422696 | AZKU00000000 | [ |
| Sal681 | Clinical | USA | 2012 | 4575 | 4492 | 150 | SAMN02422697 | AZLB00000000 | [ |
| Sal682 | Clinical | USA | 2012 | 4926 | 4944 | 377 | SAMN02422690 | AZKQ00000000 | [ |
| Sal683 | Clinical | USA | 2012 | 4574 | 4586 | 150 | SAMN02422689 | AZKP00000000 | [ |
| bovis3114 b | Clinical | Malawi | 1997 | 4680 | 4599 | 142 | SAMEA3138815 | HF969015 | [ |
| bovispt13 | Unknown | Unknown | Unknown | NA c | NA | Unknown d | SAMN01081634 | SRS347148 e | NCBI SRA |
| boviscies13 | Water | Mexico | 2013 | NA | NA | 150 | SAMN02335370 | SRS476367 f | NCBI SRA |
| pSal610 | Clinical | USA | 2011 | 93.8 | 111 | 377 | SAMN02422700 | CP076746 | This study |
a Sequence type (ST) was determined by uploading genome assemblies to https://cge.cbs.dtu.dk/services/MLST/ (accessed on 1 June 2020). b Genome size and number of CDSs of strains named with ‘Sal’ and ‘bovis’ were determined by the SEED Viewer of RAST annotation. c NA represents ‘not available’. d Nearest ST is 142. e,f Public sequence reads were downloaded from NCBI SRA (Sequence Read Archive) and locally assembled. Note: External genome sequences downloaded from NCBI were downloaded by entering the assembly accessions at the end of the URL: https://www.ncbi.nlm.nih.gov/nuccore?term= (last accessed on 6 April 2022) QDND01, MXTS01, MZFY01, QAUR01, MXXQ01, MYFY01, WFIN01, MXTX01, MXUD01, JYUT01, MXFZ01, QAUR01, AUQE01, ARYX01, AAADAU000000000.1 (for AAADAU01), NPMA01, VCTV01, AAOBOO000000000.1 (for AAOBOO01), AAIBEG000000000.1 (for AAIBEG01). Four sequence reads datasets were downloaded from NCBI SRA database: ERR1755559, SRR1783167, SRR16148890 and SRR3473097 for generating WGS assemblies for this analysis.
Figure 1Wg-core gene analysis of 95 S. Bovismorbificans identifies two distinct clusters having different genomic backbones. S. Bovismorbificans strains were obtained from clinical, animal, feed or food and water or unknown sources isolated during 1984–1989 and 2011–2018 (from this study) and representative strains from NCBI. Cluster analysis was carried out using single nucleotide polymorphisms in 2690 core genes representing conserved backbone, and the phylogenetic tree was developed using the Maximum-Likelihood method [30] available on MEGAX’s phylogenetic suite [32]. S. Typhimurium (LT2. single dot) was used as an outlier. Alleles in 48,344 positions were considered across 110 genomes spanning 2650+ out of 2690 core genes, which were considered tested over 500 bootstrapping iterations. The resulting circular tree is shown here. A browsable vertical layout of the tree is available in Supplemental Figure S1. Refer to Supplemental File S2 on the page for the comprehensive allelic data matrix from this analysis.
Figure 2Phylogenetic analysis with wg-core gene SNPs in emerging ST lineages within genome type Cluster 1 of the S. Bovismorbificans serovar. The Cluster 1 consisted of 4 major STs and diverged significantly from ST150 strains of Cluster 2. Even among these related strains in Cluster 1, emerging polymorphisms exhibiting different rates of microevolution were observed using the SNP data matrix. UPGMA tree drawn on SPlitsTree 5.0. Refer to Supplemental File S3 for details of SNPs among the strains of different Cluster 1 STs.
Figure 3k-mer-binning analysis of genomes from S. Bovismorbificans and closely related serovars. A snap shot of the Jaccard index from the k-mer-binning analysis (k = 30) of 330 WGS assemblies dataset from five Salmonella serovars was illustrated (Heatmap orange to teal blue = most divergent to most similar). S. Typhimurium (LT2Genome) and S. Muenchen (AUQE01) are closer to Cluster 1 strains (shown in sky blue), and S. Takoradi (NPMA01) is the closest serovar to the ST150 Cluster 2 strains (shown in tan). Distinct genomic pathotypes of the two S. Bovismorbificans clusters suggest evolutionarily independent hinging of a single serotyping gene cluster (“8:r:1,5”) in two different lineages of SE with different genomic backbones. The complete phylogenomic analysis with 330 genomes is presented as Supplemental File S4.
Figure 4Phylogenomic profiling of S. Bovismorbificans and closely related serovars. S. Bovismorbificans is made up strains with two distinct genomic backbones, naturally grouped into two distant clusters. Cluster 1 strains are closer to S. Typhimurium (represented by the reference genome LT2) and S. Muenchen (AUQE01 and ARYX01) than to the Cluster 2 S. Bovismorbificans strains. WGS analysis from this study identified S. Takoradi (NPMA01 and VCTV01) as the closest serovar to the Cluster 2 S. Bovismorbificans strains. S. Hindmarsh strains sharing the antigen-cluster with S. Bovismorbificans in White–Kauffmann–Le Minor scheme also exhibit different genomic backbones as in the case of S. Bovismorbificans. Two of the Hindmarsh strains are aligned with Cluster 1 (SRR1783167 and AAIBEG01), while AAADAU01 and AAOBOO01 align within Cluster 2. For this analysis, Neighbor-Joining method implemented on MEGA X suite was used yielding a data matrix made up of 46,403 base positions across 35 genomes. MLST, DNA tiling Microarray (MA), whole genome sequence (WGS) based phylogenetic analysis, core-gene alleles spanning more than 2700 core genes, and k-mer binning based on NGS datasets and conventional assays all point to two divergent genome types bearing a single serotyping cluster. SRR3473907 was not clearly serotyped either by its NCBI BioSample record or by SeqSero in this study.
Figure 5Comparison of pVirBov 3114, plasmids from Swiss strains and the closed assembly pSal610 (hummus outbreak). Closed genome of 93,777 bp long virulence plasmid from S. Bovismorbificans strain Sal610 (CP076746) was used as the reference genome to compare pVIRBov from strain 3114 [9] and a few selected Cluster 1 isolates (Table 1) from this study. BLAST+ based comparison and visualization were carried out on BRIG 0.95 [39]. White patches in a circle indicate any missing sequences in the query genome.
Figure 6ST377 strains from clinical and food sources contain a unique S. Enteriditis RE-2010-like phage. An ELPhiS prophage RE-2010 (Accession: HM770079) from S. Enteriditis LK5 [59] was identified in ST377 genomes. A comparison of representative genomes from three strains isolated from different sample sources are illustrated above: Sal610 contig 1 (AZKX01000024)—Clinical, N16_2718_contig_8 (WSCE01000008)—Clinical and N14_2376_contig_17 (WSDY01000017)—Food, Onion. The S. Bovismorbificans version of the phage appeared to be homologous with predicted additional ORFs in the structure protein core. Prevalence of other phage sequences in S. Bovismorbificans strains from this study are listed in the Supplemental File S5.
Antimicrobial resistance genes identified in the S. Bovismorbificans genomes a.
| Strain | Gene | Subclass | Sequence Name/Description |
|---|---|---|---|
| N14_0147 |
| Streptomycin | Aminoglycoside O-phosphotransferase APH(3″)-Ib |
|
| Sulfonamide | Sulfonamide-resistant dihydropteroate synthase Sul2 | |
|
| Streptomycin | Aminoglycoside O-phosphotransferase APH(6)-Id | |
| N15_0111 |
| Cephalosporin | Class A extended-spectrum beta-lactamase CTX-M-55 |
|
| Quinolone | Quinolone resistance pentapeptide repeat protein QnrS1 | |
|
| Tetracycline | Tetracycline efflux MFS transporter Tet(A) | |
|
| Beta-lactam | Class A broad-spectrum beta-lactamase TEM-1 | |
|
| Tetracycline | Tetracycline resistance ribosomal protection protein Tet(M) | |
|
| Gentamicin | Aminoglycoside N-acetyltransferase AAC(3)-IId | |
|
| Kanamycin | Aminoglycoside O-phosphotransferase APH(3′)-IIa | |
|
| Bleomycin | Bleomycin binding protein BLMT | |
|
| Bleomycin | Bleomycin binding protein | |
|
| Sulfonamide | Sulfonamide-resistant dihydropteroate synthase Sul3 | |
|
| Streptomycin | ANT(3″)-Ia family aminoglycoside Nucleotidyltransferase AadA2 | |
|
| Chloramphenicol | Chloramphenicol efflux MFS transporter CmlA1 | |
|
| Streptomycin | ANT(3″)-Ia family aminoglycoside Nucleotidyltransferase AadA1 | |
|
| Quaternary ammonium b | Quaternary ammonium compound efflux SMR transporter QacL | |
| N16_0208 |
| Streptomycin | Aminoglycoside O-phosphotransferase APH(6)-Id |
|
| Sulfonamide | Sulfonamide-resistant dihydropteroate synthase Sul2 | |
|
| Streptomycin | Aminoglycoside O-phosphotransferase APH(3″)-Ib | |
|
| Tetracycline | Tetracycline efflux MFS transporter Tet(A) | |
| N16_2574 |
| Trimethoprim | Trimethoprim-resistant dihydrofolate reductase DfrA1 |
|
| Beta-lactam | Class A broad-spectrum beta-lactamase TEM-1 | |
|
| Sulfonamide | Sulfonamide-resistant dihydropteroate synthase Sul2 | |
|
| Cephalosporin | Class A extended-spectrum beta-lactamase CTX-M-1 | |
| N16_2598 |
| Tetracycline | Tetracycline efflux MFS transporter Tet(A) |
| N16_2955 |
| Streptomycin | Aminoglycoside O-phosphotransferase APH(3″)-Ib |
|
| Streptomycin | Aminoglycoside O-phosphotransferase APH(6)-Id | |
|
| Tetracycline | Tetracycline efflux MFS transporter Tet(A) | |
|
| Sulfonamide | Sulfonamide-resistant dihydropteroate synthase Sul2 | |
| N17_0502 |
| Chloramphenicol/florfenicol | Chloramphenicol/florfenicol efflux MFS transporter FloR |
|
| Quinolone | Quinolone resistance pentapeptide repeat protein QnrB19 | |
|
| Sulfonamide | Sulfonamide-resistant dihydropteroate synthase Sul2 | |
|
| Streptomycin | Aminoglycoside O-phosphotransferase APH(3″)-Ib | |
|
| Streptomycin | Aminoglycoside O-phosphotransferase APH(6)-Id | |
|
| Tetracycline | Tetracycline efflux MFS transporter Tet(A) |
a Galaxy GenomeTrakr AMRFinder tool used for identification of antimicrobial resistance (AMR). All FASTA genomes of 98 S. Bovismorbificans were scanned, and 7 strains captured the acquired antimicrobial resistance genes. b Element type: Stress; Element subtype: Biocide.